New Haven, CT3 Active Studies

Peripheral Artery Disease Clinical Trials in New Haven, CT

Find 3 actively recruiting peripheral artery disease clinical trials in New Haven, CT. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
11,526
Enrolling

Recruiting Peripheral Artery Disease Studies in New Haven

About Peripheral Artery Disease Clinical Trials in New Haven

Peripheral artery disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, especially the legs. Common symptoms include leg pain when walking (claudication). Treatment includes lifestyle changes, medications, and sometimes procedures to improve blood flow.

There are currently 3 peripheral artery disease clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 11,526 participants. Research is being sponsored by Population Health Research Institute, Boston Scientific Corporation, M.A. Med Alliance S.A.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral Artery Disease Clinical Trials in New Haven — FAQ

Are there peripheral artery disease clinical trials in New Haven?

Yes, there are 3 peripheral artery disease clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What peripheral artery disease treatments are being tested?

The 3 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral artery disease.

Data updated July 17, 2026 from ClinicalTrials.gov